A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
- PMID: 32495148
- PMCID: PMC7269161
- DOI: 10.1007/s40264-020-00955-y
A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
Abstract
Introduction: Hydroxychloroquine was recently promoted in patients infected with COVID-19 infection. A recent experimental study has suggested an increased toxicity of hydroxychloroquine in association with metformin in mice.
Objective: The present study was undertaken to investigate the reality of this putative drug-drug interaction between hydroxychloroquine and metformin using pharmacovigilance data.
Methods: Using VigiBase®, the WHO pharmacovigilance database, we performed a disproportionality analysis (case/non-case study). Cases were reports of fatal outcomes with the drugs of interest and non-cases were all other reports for these drugs registered between 1 January 2000 and 31 December 2019. Data with hydroxychloroquine (or metformin) alone were compared with the association hydroxychloroquine + metformin. Results are reported as ROR (reporting odds ratio) with their 95% confidence interval.
Results: Of the 10,771 Individual Case Safety Reports (ICSR) involving hydroxychloroquine, 52 were recorded as 'fatal outcomes'. In comparison with hydroxychloroquine alone, hydroxychloroquine + metformin was associated with an ROR value of 57.7 (23.9-139.3). In comparison with metformin alone, hydroxychloroquine + metformin was associated with an ROR value of 6.0 (2.6-13.8).
Conclusion: Our study identified a signal for the association hydroxychloroquine + metformin that appears to be more at risk of fatal outcomes (particularly by completed suicides) than one of the two drugs when given alone.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):187-188. doi: 10.1007/s10928-020-09689-x. Epub 2020 May 13. J Pharmacokinet Pharmacodyn. 2020. PMID: 32405664 Free PMC article. No abstract available.
-
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System.Front Immunol. 2024 Dec 20;15:1470660. doi: 10.3389/fimmu.2024.1470660. eCollection 2024. Front Immunol. 2024. PMID: 39759530 Free PMC article.
-
Does hydroxychloroquine combat COVID-19? A timeline of evidence.J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10. J Am Acad Dermatol. 2020. PMID: 32283236 Free PMC article. No abstract available.
-
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20. Indian J Public Health. 2020. PMID: 32496241 Review.
-
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?Clin Rheumatol. 2020 Aug;39(8):2461-2465. doi: 10.1007/s10067-020-05202-4. Epub 2020 Jun 3. Clin Rheumatol. 2020. PMID: 32495226 Free PMC article. Review.
Cited by
-
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit.Front Endocrinol (Lausanne). 2021 Jul 22;12:587801. doi: 10.3389/fendo.2021.587801. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34367059 Free PMC article. Review.
-
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?Behav Sci (Basel). 2021 Nov 7;11(11):154. doi: 10.3390/bs11110154. Behav Sci (Basel). 2021. PMID: 34821615 Free PMC article.
-
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.Pharmacol Res. 2020 Nov;161:105250. doi: 10.1016/j.phrs.2020.105250. Epub 2020 Oct 13. Pharmacol Res. 2020. PMID: 33059010 Free PMC article.
-
Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients.Afr Health Sci. 2022 Dec;22(4):597-606. doi: 10.4314/ahs.v22i4.65. Afr Health Sci. 2022. PMID: 37092113 Free PMC article.
-
The Current and Potential Therapeutic Use of Metformin-The Good Old Drug.Pharmaceuticals (Basel). 2021 Feb 5;14(2):122. doi: 10.3390/ph14020122. Pharmaceuticals (Basel). 2021. PMID: 33562458 Free PMC article. Review.
References
-
- Vinetz JM. Chemotherapy of malaria. In: Brunton LL, Hilal-Dandan R, Knollmann BJ, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 13. New York: McGraw Hill; 2018. pp. 968–986.
-
- Roustit M, Guilhaumou R, Molimard M, Milou Drici M, Laporte S, Montastruc JL, On behalf of the French Society of Pharmacology and Therapeutics (SFPT) Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence. Therapie. 2020 doi: 10.1016/j.therap.2020.05.010Reference. - DOI - PMC - PubMed
-
- Rajeshkumar NV, Yabuuchi S, Pai SG, Maitra A, Hidalgo M, Dang CV. Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice. Biorxiv. 2020 doi: 10.1101/2020.03.31.018556. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical